$CODX COVID-19 test kits to be sold in India. The company’s joint venture in India, CoSara Diagnostics, has become the first and only Indian company to receive a license from the Central Drugs Standards Control Organization (CDSCO) to manufacture reverse transcription polymerase chain reaction (RT-PCR) test kits for COVID-19. The test kit approved by CDSCO is the same as the one originally designed by Co-Diagnostics and subsequently approved as CE IVD. Test kits manufactured by CoSara are expected to be sold in the Indian market, targeting 52 government-approved testing facilities as well as 60 accredited private labs.
  • 3
  • 1